UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

IVIG-mediated effector functions in autoimmune and inflammatory diseases

International immunology, 2017-12, Vol.29 (11), p.491-498

2017

Volltextzugriff (PDF)

Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients

Cell reports. Medicine, 2020-05, Vol.1 (2), p.100016-100016, Article 100016

2020

Volltextzugriff (PDF)

Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the Way

Cell host & microbe, 2016-11, Vol.20 (5), p.555-557

2016

Volltextzugriff (PDF)

Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy

Cell death & disease, 2020-01, Vol.11 (1), p.50-50, Article 50

2020

Volltextzugriff (PDF)

Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4⁺ T Cell Responses

Molecules (Basel, Switzerland), 2016-07, Vol.21 (7), p.912

2016

Volltextzugriff (PDF)

Intravenous immunoglobulin as clinical immune-modulating therapy

Canadian Medical Association journal (CMAJ), 2015-03, Vol.187 (4), p.257

2015

Volltextzugriff (PDF)

Human basophils may not undergo modulation by DC-SIGN and mannose receptor–targeting immunotherapies due to absence of receptors

Journal of allergy and clinical immunology, 2017-04, Vol.139 (4), p.1403-1404.e1

2017

Volltextzugriff (PDF)

Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin

Trends in immunology, 2017-11, Vol.38 (11), p.789-792

2017

Volltextzugriff (PDF)

IVIg for relapsing–remitting multiple sclerosis: promises and uncertainties

Trends in pharmacological sciences (Regular ed.), 2015-07, Vol.36 (7), p.419-421

2015

Volltextzugriff (PDF)

Anti-inflammatory activity of intravenous immunoglobulin through scavenging of heme

Molecular immunology, 2019-07, Vol.111, p.205-208

2019

Volltextzugriff (PDF)

Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patients

Immunologic research, 2014-12, Vol.60 (2-3), p.320-329

2014

Volltextzugriff (PDF)

Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients

Scientific reports, 2014-07, Vol.4 (1), p.5672-5672, Article 5672

2014

Volltextzugriff (PDF)

Intravenous immunoglobulin: an update on the clinical use and mechanisms of action

Journal of Clinical Immunology, 2007-05, Vol.27 (3), p.233-245

2007

Volltextzugriff (PDF)

Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action

Nature clinical practice. Rheumatology, 2007-05, Vol.3 (5), p.262-272

2007

Volltextzugriff (PDF)

Protein destabilizing agents induce polyreactivity and enhanced immunomodulatory activity in IVIg preparations

Autoimmunity (Chur, Switzerland), 2009-01, Vol.42 (4), p.365-367

2009

Volltextzugriff (PDF)

Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective

Annals of the New York Academy of Sciences, 2007-09, Vol.1110 (1), p.497-506

2007

Volltextzugriff (PDF)

Treatment with polyclonal immunoglobulin during T-cell reconstitution promotes naive T-cell proliferation

Journal of immunotherapy, 2010-07, Vol.33 (6), p.618-625

2010

Volltextzugriff (PDF)

Induction of Natural Autoantibody Activity Following Treatment of Human Immunoglobulin with Dissociating Agents

Journal of autoimmunity, 2001-03, Vol.16 (2), p.163-172

2001

Volltextzugriff (PDF)

Dendritic cells and autoimmunity

Autoimmunity reviews, 2004-03, Vol.3 (3), p.183-187

2004

Volltextzugriff (PDF)

Pooled Normal Human Polyspecific IgM Contains Neutralizing Anti-Idiotypes to IgG Autoantibodies of Autoimmune Patients and Protects From Experimental Autoimmune Disease

Blood, 1997-11, Vol.90 (10), p.4004-4013

1997

Volltextzugriff (PDF)

Antibody profile in Indian severe haemophilia A patients with and without FVIII inhibitors

Immunology letters, 2016-01, Vol.169, p.93-97

2016

Volltextzugriff (PDF)

Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use

The Journal of clinical investigation, 1996-02, Vol.97 (3), p.865-869

1996

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

ThemaHumans

ThemaImmunotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Immunology
(20)
Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Life Sciences
(13)
Immunoglobulins, Intravenous - Therapeutic Use
(10)
Immunoglobulins, Intravenous - Immunology
(9)
Animals
(7)
Autoimmune Diseases - Immunology
(7)
Autoimmunity
(7)
Dendritic Cells
(6)
Immunoglobulins
(6)
Inflammation
(6)
Ivig
(6)
Cytokines
(5)
Intravenous Immunoglobulin
(5)
Mice
(5)
Allergology
(4)
Autoimmune Diseases - Therapy
(4)

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IVIG-mediated effector functions in autoimmune and inflammatory diseases

Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients

Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the Way

Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy

Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4⁺ T Cell Responses

Intravenous immunoglobulin as clinical immune-modulating therapy

Human basophils may not undergo modulation by DC-SIGN and mannose receptor–targeting immunotherapies due to absence of receptors

Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin

IVIg for relapsing–remitting multiple sclerosis: promises and uncertainties

Anti-inflammatory activity of intravenous immunoglobulin through scavenging of heme

Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain–Barré syndrome patients

Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients

Intravenous immunoglobulin: an update on the clinical use and mechanisms of action

Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action

Protein destabilizing agents induce polyreactivity and enhanced immunomodulatory activity in IVIg preparations

Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective

Treatment with polyclonal immunoglobulin during T-cell reconstitution promotes naive T-cell proliferation

Induction of Natural Autoantibody Activity Following Treatment of Human Immunoglobulin with Dissociating Agents

Dendritic cells and autoimmunity

Pooled Normal Human Polyspecific IgM Contains Neutralizing Anti-Idiotypes to IgG Autoantibodies of Autoimmune Patients and Protects From Experimental Autoimmune Disease

Antibody profile in Indian severe haemophilia A patients with and without FVIII inhibitors

Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use

Aktive Filter

Suchergebnisse filtern